|
0
|
|
Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial Sexually Transmitted Infections: A Secondary Analysis of HPTN 083.
(academic.oup.com)
|
Clement ME
…
Landovitz RJ
Clinical Infectious Diseases
2026-02-25
|
#infection
#amr
#clinical trial
#prevention
#hiv
|
|
0
|
|
Prevention of Tuberculosis in Patients Treated With Biological Therapies: 20 Years' Experience in a Specialized Tuberculosis Clinic in a Low-prevalence Country.
(academic.oup.com)
|
Perez-Recio S
…
Santin M
Clinical Infectious Diseases
2026-02-25
|
#infection
#immunosuppression
#screening
#prevention
#tb
|
|
0
|
|
Risk Assessment in a Global CVD Prevention Cohort of People With HIV by PCE, PREVENT, and SCORE2.
(academic.oup.com)
|
Grinspoon SK
…
Zanni MV
Clinical Infectious Diseases
2026-02-25
|
#clinical trial
#prevention
#hiv
#cardiovascular
#risk stratification
|
|
0
|
|
Sexually Transmitted Infection (STI)/HIV Testing, STIs, and HIV Pre-exposure Prophylaxis Use Among Men Who Have Sex With Men and Men Who Have Sex With Men and Women in the United States, 2019-2022.
(academic.oup.com)
|
Tao G
…
Workowski K
Clinical Infectious Diseases
2026-02-25
|
#infection
#screening
#epidemiology
#prevention
|